IKZF1 and systemic lupus erythematosus: CC-220 (iberdomide) is another analog of thalidomide, which enhances the efficacy to downregulate Ikaros and Aiolos by tightly binding to CRL4CRBN E3 ligase for the treatment of RRMM and SLE (Matyskiela et al., 2018).